The Treatment of Magnesium Sulfate and Nifedipine in Preterm Labor Threat

• Status: Recruiting
• Trial end date: 2023-03-31
• Target enrollment: 0
• Participant gender: Female

Summary

Comparison of the effects of Nifedipine and MgSO4 therapies on maternal and fetal blood flow.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Konya Meram State Hospital
• Treatments: Magnesium Sulfate; Nifedipine

Criteria

Inclusion Criteria:

• pregnancies with preterm labor threat between 28-34 weeks gestational ages

Exclusion Criteria:

• Cervical dilatation at > 4 cm and/or cervical effacement >80%,

• Multiple pregnancies,

• Pregnancy complications including preeclampsia, ablatio placenta, intrauterine growth restriction, placenta previa, gestational diabetes